Pharma Times -- Bayer is putting in place measures which it claims will cut down on administration and promote innovation. The German group’s pharmaceutical business, previously Bayer Schering Pharma, will operate as a division called Bayer HealthCare Pharmaceuticals under the leadership of Andreas Fibig, and its headquarters will remain in Berlin. Also, as from March, Andreas Busch and Kemal Malik, respectively heads of pharma research and pharma development, will report directly to Joerg Reinhardt, the boss of Bayer HealthCare (BHC).
